Journal article
Sponsorship bias in oncology cost effectiveness analysis
Abstract
OBJECTIVES: Cost effectiveness analysis (CEA) has been increasingly used to inform cancer treatment coverage policy making worldwide. The primary objective of this study was to assess the association between industry sponsorship and CEA results in oncology.
STUDY DESIGN AND SETTING: All CEAs in oncology used incremental cost per quality-adjusted life year (QALY) as health effect identified from the Tufts CEA Registry since 1976 was analyzed. …
Authors
Zhou T; Xie F
Journal
Journal of Clinical Epidemiology, Vol. 156, , pp. 22–29
Publisher
Elsevier
Publication Date
April 2023
DOI
10.1016/j.jclinepi.2023.02.011
ISSN
0895-4356